Shares of Cognyte Software program Ltd. (NASDAQ:CGNT – Get Ranking) have earned a mean suggestion of “Maintain” from the six analysis companies which can be at present protecting the agency, MarketBeat.com stories. 5 analysis analysts have rated the inventory with a maintain ranking and one has issued a purchase ranking on the corporate. The common 1-year goal value amongst analysts who’ve up to date their protection on the inventory within the final yr is $9.00.
Numerous fairness analysts just lately issued stories on CGNT shares. StockNews.com raised Cognyte Software program from a “promote” ranking to a “maintain” ranking in a report on Tuesday, October twenty fifth. Stifel Nicolaus downgraded shares of Cognyte Software program from a “purchase” ranking to a “maintain” ranking and diminished their value goal for the corporate from $8.00 to $6.00 in a analysis report on Wednesday, September twenty eighth.
Institutional Buyers Weigh In On Cognyte Software program
Hedge funds and different institutional buyers have just lately modified their holdings of the inventory. Bayesian Capital Administration LP acquired a brand new stake in shares of Cognyte Software program through the third quarter valued at roughly $42,000. Legacy Advisors LLC acquired a brand new stake in shares of Cognyte Software program through the 2nd quarter valued at roughly $43,000. Quantbot Applied sciences LP acquired a brand new stake in shares of Cognyte Software program through the 1st quarter valued at roughly $45,000. Keebeck Alpha LP acquired a brand new stake in shares of Cognyte Software program through the 2nd quarter valued at roughly $46,000. Lastly, Handelsbanken Fonder AB lifted its place in shares of Cognyte Software program by 16.3% through the 2nd quarter. Handelsbanken Fonder AB now owns 15,700 shares of the medical gadget firm’s inventory valued at $67,000 after buying an extra 2,200 shares through the interval. 88.90% of the inventory is at present owned by institutional buyers and hedge funds.
Cognyte Software program Inventory Down 1.9 %
NASDAQ CGNT opened at $3.13 on Friday. Cognyte Software program has a 52-week low of $2.55 and a 52-week excessive of $21.47. The enterprise’s 50-day transferring common value is $3.39 and its 200-day transferring common value is $4.75. The agency has a market cap of $211.22 million, a P/E ratio of -3.01 and a beta of 1.33.
Cognyte Software program (NASDAQ:CGNT – Get Ranking) final launched its quarterly earnings outcomes on Wednesday, September twenty eighth. The medical gadget firm reported earnings per share (EPS) for the quarter, lacking analysts’ consensus estimates of ($0.25) by ($0.18). Cognyte Software program had a adverse return on fairness of 34.07% and a adverse internet margin of 16.91%. The corporate had income of $81.10 million for the quarter, in comparison with analysts’ expectations of $92.47 million. Throughout the identical interval within the prior yr, the enterprise earned $0.17 EPS. The enterprise’s quarterly income was down 30.1% in comparison with the identical quarter final yr. As a bunch, analysts anticipate that Cognyte Software program will put up -1.35 earnings per share for the present yr.
Cognyte Software program Firm Profile
Cognyte Software program Ltd. gives an investigative analytics software program to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software program designed to assist governments and enterprises speed up and improve the effectiveness of investigations. The corporate additionally presents community intelligence analytics, open supply and menace intelligence analytics, and operational intelligence analytics options.
Obtain Information & Rankings for Cognyte Software program Each day – Enter your e-mail handle under to obtain a concise every day abstract of the newest information and analysts’ rankings for Cognyte Software program and associated corporations with MarketBeat.com’s FREE every day e-mail e-newsletter.